ONTEX 📈 Ontex - Overview
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974276082
ONTEX: Diapers, Wipes, Sanitary Towels, Tampons, Adult Incontinence Products
Ontex Group NV develops, produces, and supplies personal hygiene products and solutions for baby, feminine, and adult care in Belgium, the United Kingdom, the United States, Italy, France, and internationally. It offers baby care products, such as baby diapers and pants, and wet wipes under the Cremer, Canbebe, Helen Harper, Little Big Change, Moltex, Pom Pom, Sapeka, and Mônica brands; and feminine care products, including sanitary towels, panty liners, and tampons under the NAT, Sincere, and Silhouette brand names. The company also provides adult care products comprising adult pants and diapers, incontinence towels, and bed protection products under the A Lovely Day, Adultmax Maturidade, Bigfral, iD, Canped, Lille Healthcare, Kylie, Serenity, Orizon, and Moviment brands. It sells its products to consumers, retailers, and institutional and private healthcare providers, as well as offers products under retailer brands. Ontex Group NV was founded in 1979 and is headquartered in Aalst, Belgium. Ontex Group NV operates as a subsidiary of Groupe Bruxelles Lambert SA. Web URL: https://ontex.com
Additional Sources for ONTEX Stock
ONTEX Stock Overview
Market Cap in USD | 692m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
ONTEX Stock Ratings
Growth 5y | -48.1% |
Fundamental | 37.2% |
Dividend | 12.2% |
Rel. Strength Industry | -46.5 |
Analysts | - |
Fair Price Momentum | 6.91 EUR |
Fair Price DCF | 42.37 EUR |
ONTEX Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 40.5% |
ONTEX Growth Ratios
Growth Correlation 3m | -49.3% |
Growth Correlation 12m | 28.6% |
Growth Correlation 5y | -58.9% |
CAGR 5y | -14.15% |
CAGR/Mean DD 5y | -0.27 |
Sharpe Ratio 12m | 0.16 |
Alpha | -8.89 |
Beta | 0.46 |
Volatility | 28.02% |
Current Volume | 94.6k |
Average Volume 20d | 98.3k |
What is the price of ONTEX stocks?
As of December 22, 2024, the stock is trading at EUR 8.02 with a total of 94,622 shares traded.
Over the past week, the price has changed by -0.87%, over one month by +7.40%, over three months by -9.63% and over the past year by +7.26%.
As of December 22, 2024, the stock is trading at EUR 8.02 with a total of 94,622 shares traded.
Over the past week, the price has changed by -0.87%, over one month by +7.40%, over three months by -9.63% and over the past year by +7.26%.
Is Ontex a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Ontex (BR:ONTEX) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.16 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ONTEX as of December 2024 is 6.91. This means that ONTEX is currently overvalued and has a potential downside of -13.84%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ontex (BR:ONTEX) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.16 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ONTEX as of December 2024 is 6.91. This means that ONTEX is currently overvalued and has a potential downside of -13.84%.
Is ONTEX a buy, sell or hold?
Ontex has no consensus analysts rating.
Ontex has no consensus analysts rating.
What are the forecast for ONTEX stock price target?
According to ValueRays Forecast Model, ONTEX Ontex will be worth about 7.5 in December 2025. The stock is currently trading at 8.02. This means that the stock has a potential downside of -6.86%.
According to ValueRays Forecast Model, ONTEX Ontex will be worth about 7.5 in December 2025. The stock is currently trading at 8.02. This means that the stock has a potential downside of -6.86%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 11.2 | 39.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 7.5 | -6.9% |